Sensorium Therapeutics, Inc.
Boston, MA
- UEI
- TH8QS62WDCH3
- CAGE
- 9HMK3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 40 Guest St, Brighton, MA 02135, USA
- Website
- sensorium.bio
- Founded
- 2021
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A drug discovery platform to prioritize development of natural product neuromodulators for treating cognitive impairment | National Institute on Aging (NIH) | $4,542,379 |
Quick answers
Is Sensorium Therapeutics, Inc. registered in SAM.gov?
Yes. Sensorium Therapeutics, Inc.'s SAM.gov registration is active through March 17, 2027.
What is Sensorium Therapeutics, Inc.'s most recent federal award?
Sensorium Therapeutics, Inc.'s most recent federal grant award is A drug discovery platform to prioritize development of natural product neuromodulators for treating cognitive impairment (R44AG085858), from National Institute on Aging (NIH), on December 1, 2023.
On GovTribe
See Sensorium Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors